Overview
Enfusion provides a cloud-native, multi-tenant software platform for asset managers that unifies portfolio management, order and execution management, and accounting in a single system. It delivers real-time data across front, middle, and back-office to help portfolio managers and trading desks coordinate and access up-to-date information without switching between apps. The platform uses subscription-based SaaS with optional managed services and frequent non-disruptive upgrades, allowing clients to add new asset classes with less operational change. Now part of Clearwater Analytics, Enfusion targets hedge funds, institutional managers, and family offices and aims to cover the entire investment lifecycle from trading to accounting.
Work here?Claim your company
Simplify's take
What believers are saying
- Nearly 900 clients ran agentic workflows in production by September 2026.
- Clearwater won PREPAR-VIE and MSIG Europe in 2026, expanding distribution for Enfusion modules.
- Corgi Funds' July 2026 launch signals strong demand for ETF automation and managed services.
What critics are saying
- Permira and Warburg Pincus now own Clearwater, pressuring Enfusion integration and headcount rationalization in 2026.
- Bloomberg partnership at NFU Mutual shows rivals can displace Enfusion on strategic workflows quickly.
- If Clearwater de-emphasizes Enfusion branding, product identity fades and customer defections accelerate by 2027.
What makes Enfusion unique
- Enfusion by Clearwater combines portfolio, trading, risk, and back-office workflows in one platform.
- Clearwater keeps winning front-to-back mandates, including PREPAR-VIE and NFU Mutual in 2026.
- Corgi Funds scaled to 188 ETFs on Enfusion by Clearwater, proving automation depth.
Help us improve and share your feedback! Did you find this helpful?